Humana Stock Near Crucial Support – Buy Signal?
Humana (HUM) stock should be on your watchlist. Here is why – it is currently trading in the support zone ($280.58 – $310.12), levels from which it has bounced meaningfully before. Since it first started trading, Humana stock received buying interest at this level 4 times and subsequently went on to generate 39.6% in average peak returns.
| Peak Return | Days to Peak Return | |
|---|---|---|
| 4/2/2018 | 6.3% | 16 |
| 5/10/2018 | 26.0% | 181 |
| 10/15/2019 | 37.6% | 121 |
| 3/26/2020 | 88.4% | 952 |
Yet, a support zone alone isn’t enough; rebounds are more likely when fundamentals, sentiment, and market conditions line up. How does that look for HUM?
Sustained Rebound Unlikely
Humana’s Q1 adjusted EPS beat, but revenue slightly missed, while FY26 GAAP guidance was lowered. Strategic 2027 Medicare Advantage benefit cuts reflect ongoing margin pressure from insufficient CMS payment rates and elevated medical costs. Analyst consensus is ‘Hold,’ with average price targets below current levels, signaling skepticism. While MA margin recovery initiatives and strong Special Needs Plan growth provide some counterpoint, pervasive industry headwinds challenge a durable rebound from this price support.
- Cash Rich, Low Price – CDW Stock to Break Out?
- Years of Rewards: $34 Bil From Eli Lilly Stock
- Costco Wholesale Stock Capital Return Hits $20 Bil
- Arista Networks Stock Hits Key Support – Buying Opportunity?
- Booking Stock Delivers Strong Cash Yield – Upside Ahead?
- SMCI Looks Smarter Buy Than Hewlett Packard Enterprise Stock
How Do HUM Financials Look Right Now?
- Revenue Growth: 14.1% LTM and 12.8% last 3-year average.
- Cash Generation: Nearly 0.9% free cash flow margin and 0.0% operating margin LTM.
- Recent Revenue Shocks: The minimum annual revenue growth in the last 3 years for HUM was 10.1%.
- Valuation: HUM stock trades at a PE multiple of 31.5
| HUM | S&P Median | |
|---|---|---|
| Sector | Health Care | – |
| Industry | Managed Health Care | – |
| PE Ratio | 31.5 | 23.5 |
|
|
||
| LTM* Revenue Growth | 14.1% | 7.4% |
| 3Y Average Annual Revenue Growth | 12.8% | 5.7% |
| Min Annual Revenue Growth Last 3Y | 10.1% | 0.8% |
|
|
||
| LTM* Operating Margin | � | 18.4% |
| 3Y Average Operating Margin | � | 18.3% |
| LTM* Free Cash Flow Margin | 0.9% | 14.4% |
*LTM: Last Twelve Months | For more details on HUM fundamentals, read Buy or Sell HUM Stock.
And What If The Support Breaks?
HUM shows it’s not immune to tough markets. It plunged about 77% during the Dot-Com Bubble and nearly 78% in the Global Financial Crisis. Even in the 2018 Correction and Covid sell-off, it dropped 34% and 44%, respectively. The Inflation Shock wasn’t kind either, with a 24% dip. Solid fundamentals matter, but HUM’s history reminds us that big drawdowns happen even with good companies.
But the risk is not limited to major market crashes. Stocks fall even when markets are in good shape – think events like earnings, business updates, outlook changes. Read HUM Dip Buyer Analyses to see how the stock has recovered from sharp dips in the past.
Still not sure about HUM stock? Consider the portfolio approach.
The Best Investors Think In Portfolios
Individual stocks are unpredictable. A smart portfolio helps you invest, limits downside shocks, and provides upside exposure.
The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? HQ Portfolio has posted more than 105% in cumulative return since inception, with less risk versus the benchmark index, as evident in HQ Portfolio performance metrics.